JP2015221809A5 - - Google Patents

Download PDF

Info

Publication number
JP2015221809A5
JP2015221809A5 JP2015134900A JP2015134900A JP2015221809A5 JP 2015221809 A5 JP2015221809 A5 JP 2015221809A5 JP 2015134900 A JP2015134900 A JP 2015134900A JP 2015134900 A JP2015134900 A JP 2015134900A JP 2015221809 A5 JP2015221809 A5 JP 2015221809A5
Authority
JP
Japan
Prior art keywords
patient
disease
antigenic composition
composition according
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015134900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015221809A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015221809A publication Critical patent/JP2015221809A/ja
Publication of JP2015221809A5 publication Critical patent/JP2015221809A5/ja
Pending legal-status Critical Current

Links

JP2015134900A 2009-03-18 2015-07-06 治療的使用のための方法 Pending JP2015221809A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16116509P 2009-03-18 2009-03-18
US61/161,165 2009-03-18
US25602809P 2009-10-29 2009-10-29
US61/256,028 2009-10-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012500251A Division JP2012520852A (ja) 2009-03-18 2010-03-18 治療的使用のための方法

Publications (2)

Publication Number Publication Date
JP2015221809A JP2015221809A (ja) 2015-12-10
JP2015221809A5 true JP2015221809A5 (cg-RX-API-DMAC7.html) 2016-02-25

Family

ID=42376556

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012500251A Withdrawn JP2012520852A (ja) 2009-03-18 2010-03-18 治療的使用のための方法
JP2015134900A Pending JP2015221809A (ja) 2009-03-18 2015-07-06 治療的使用のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012500251A Withdrawn JP2012520852A (ja) 2009-03-18 2010-03-18 治療的使用のための方法

Country Status (17)

Country Link
US (1) US20100285108A1 (cg-RX-API-DMAC7.html)
EP (2) EP3978517A1 (cg-RX-API-DMAC7.html)
JP (2) JP2012520852A (cg-RX-API-DMAC7.html)
KR (1) KR20120004994A (cg-RX-API-DMAC7.html)
CN (1) CN102428101B (cg-RX-API-DMAC7.html)
AU (1) AU2010224824B2 (cg-RX-API-DMAC7.html)
CA (1) CA2755683A1 (cg-RX-API-DMAC7.html)
DK (1) DK2408807T3 (cg-RX-API-DMAC7.html)
ES (1) ES2885398T3 (cg-RX-API-DMAC7.html)
HU (1) HUE055739T2 (cg-RX-API-DMAC7.html)
IL (1) IL214919A (cg-RX-API-DMAC7.html)
MX (1) MX2011009654A (cg-RX-API-DMAC7.html)
PT (1) PT2408807T (cg-RX-API-DMAC7.html)
RU (1) RU2579659C2 (cg-RX-API-DMAC7.html)
SG (1) SG174871A1 (cg-RX-API-DMAC7.html)
SI (1) SI2408807T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010106127A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
EP4218794A3 (en) * 2009-06-10 2023-09-13 New York University Immunological targeting of pathological tau proteins
WO2012045882A2 (en) * 2010-10-07 2012-04-12 Ac Immune S.A. Pharmaceutical composition
AU2013205313B2 (en) * 2010-10-07 2016-05-19 Ac Immune S.A. Phosphospecific antibodies recognising tau
CA2811188C (en) * 2011-09-23 2020-04-28 Andrea Pfeifer Vaccine therapy
JP6358953B2 (ja) 2011-10-07 2018-07-18 エーシー イミューン エス.エー. タウを認識するホスホ特異的抗体
CA2869438C (en) 2012-04-05 2021-08-17 Ac Immune S.A. Humanized tau antibody
EP2847322B1 (en) 2012-05-08 2019-06-26 Western University Of Health Sciences Standardized ex vivo platforms for the antigen-specific expansion of cd4+ t cell populations
MX374811B (es) 2013-03-15 2025-03-06 Ac Immune Sa Anticuerpos anti-tau y métodos de uso.
EP3166688B1 (en) 2014-07-08 2024-08-21 New York University Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
EP3261678B8 (en) * 2015-01-23 2021-03-17 Helix Biopharma Corp. Antibody-urease conjugates for therapeutic purposes
US10988528B2 (en) 2015-08-13 2021-04-27 New York University Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
TW202333768A (zh) 2017-10-25 2023-09-01 美商健生醫藥公司 Tau胜肽之組成物及其用途
KR20210124308A (ko) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. 항-gal3 항체 및 이의 용도
SG11202108312PA (en) 2019-02-08 2021-08-30 Ac Immune Sa Method of safe administration of phosphorylated tau peptide vaccine
MX2021012994A (es) * 2019-04-24 2022-03-04 Janssen Pharmaceuticals Inc Administracion heterologa de vacunas tau.
CN113853214A (zh) * 2019-05-21 2021-12-28 Ac免疫有限公司 抗Aβ疫苗治疗
MX2022014786A (es) 2020-05-26 2023-01-16 Truebinding Inc Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
KR20250135293A (ko) 2023-01-26 2025-09-12 에이씨 이뮨 에스에이 리포좀 구조체

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7408027B1 (en) * 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease
AU690092B2 (en) * 1992-12-14 1998-04-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
WO1997034145A1 (fr) * 1996-03-13 1997-09-18 Mitsubishi Chemical Corporation Anticorps a proteine tau antiphosphorylee et procede de detection de la maladie d'alzheimer l'utilisant
WO1998022120A1 (en) * 1996-11-19 1998-05-28 The Wistar Institute Of Anatomy & Biology Diagnostic and therapeutic reagents for alzheimer's disease
AU2001273361A1 (en) * 2000-07-11 2002-01-21 Molecular Geriatrics Corporation Reagents and methods for identification of binding agents
KR20050101537A (ko) 2002-12-24 2005-10-24 뉴로켐 (인터내셔널) 리미티드 베타-아밀로이드 관련 질환의 치료를 위한 치료 제제
US8663650B2 (en) * 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
EP1494000A1 (en) * 2003-07-02 2005-01-05 Sicpa Holding S.A. Method of marking a material with ions already comprised in said material and method of verifying the authenticity of said material
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
KR101277004B1 (ko) * 2004-02-20 2013-06-24 에이씨 이뮨 에스.에이. 초분자 구조체를 포함하는 방법 및 조성물
CA2633399C (en) * 2005-12-12 2016-01-26 Ac Immune S.A. Therapeutic vaccine
US8012936B2 (en) * 2006-03-29 2011-09-06 New York University Tau fragments for immunotherapy
US20080220449A1 (en) * 2007-02-08 2008-09-11 Oligomerix, Inc. Biomarkers and assays for Alzheimer's disease
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція

Similar Documents

Publication Publication Date Title
RU2011141889A (ru) Способ для применения в терапии
JP2012520852A5 (cg-RX-API-DMAC7.html)
JP2011251964A5 (cg-RX-API-DMAC7.html)
JP2014531455A5 (cg-RX-API-DMAC7.html)
AR058327A1 (es) Vacuna terapeutica
US20240350598A1 (en) Anti-Abeta Therapeutic Vaccines
AR078085A1 (es) Peptidos tau antigenicos y usos de los mismos
Jagessar et al. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant
CN110691599B (zh) 使用脂多糖的脑功能改善剂、食品和药品
Davtyan et al. Immunogenicity of DNA-and recombinant protein-based Alzheimer disease epitope vaccines
Kafami et al. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function
AU2021200093B2 (en) Treatment and prevention of alzheimer's disease (ad)
WO2015165961A1 (en) Treatment and prevention of alzheimer's disease (ad)
Mohajeri et al. Prevention of age-associated dementia
KR20240147981A (ko) 항-알파시누클레인 치료 백신
KR102506460B1 (ko) 알츠하이머병(ad)의 치료 및 예방
Coppes et al. Severe early bilateral macular edema following fingolimod therapy
WO2015165980A2 (en) Treatment and prevention of alzheimer's disease (ad)
WO2010035261A3 (en) Amyloid beta-peptides and methods of use thereof
US10478454B2 (en) Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide
Mohammed et al. Co-morbid Guillain-Barré syndrome and acute disseminated encephalomyelitis
RU2013139704A (ru) Применение белка yb-1 и его фрагментов для изготовления лекарственных средств при лечении болезни альцгеймера
Marciani Development of an effective Alzheimer’s vaccine
Arruda et al. Primary lateral sclerosis: a case report with spect study
Robles-Cedeno et al. A Moroccan patient with Vogt–Koyanagi–Harada syndrome and bilateral Adie’s pupils